| Literature DB >> 27819188 |
Todd A Goldstein1,2, Casey J Epstein1, John Schwartz1, Alex Krush1, Dan J Lagalante1, Kevin P Mercadante1, David Zeltsman1,2, Lee P Smith1,2, Daniel A Grande1,2.
Abstract
Numerous studies have shown the capabilities of three-dimensional (3D) printing for use in the medical industry. At the time of this publication, basic home desktop 3D printer kits can cost as little as $300, whereas medical-specific 3D bioprinters can cost more than $300,000. The purpose of this study is to show how a commercially available desktop 3D printer could be modified to bioprint an engineered poly-l-lactic acid scaffold containing viable chondrocytes in a bioink. Our bioprinter was used to create a living 3D functional tissue-engineered cartilage scaffold. In this article, we detail the design, production, and calibration of this bioprinter. In addition, the bioprinted cells were tested for viability, proliferation, biochemistry, and gene expression; these tests showed that the cells survived the printing process, were able to continue dividing, and produce the extracellular matrix expected of chondrocytes.Entities:
Keywords: 3D printing; bioink; bioprinting; cartilage; tissue engineering
Mesh:
Substances:
Year: 2016 PMID: 27819188 DOI: 10.1089/ten.TEC.2016.0286
Source DB: PubMed Journal: Tissue Eng Part C Methods ISSN: 1937-3384 Impact factor: 3.056